Clinical Trial

Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and Outcomes

Study acronym: UNCOVER
Completed
View on ClinicalTrials.gov →
Summary
This is a retrospective, cross-sectional, non-interventional, multi-country survey-based chart audit study to evaluate real-world treatment patterns, patient clinical profiles, and clinical outcomes among a NSCLC patients receiving at least 1L SACT (Systemic anticancer therapy)
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-10-08; most recent amendment 2026-03-09.
Status change: Enrolling by Invitation → Completed 2026-03-09
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-12-19
Trial Details
NCT Number NCT07215026
Lead Sponsor AstraZeneca
Conditions Non-small Cell Lung Cancer
Enrollment 833 participants
Start Date 2025-10-27
Primary Completion 2026-01-21 (estimated)
Study Completion 2026-01-21 (estimated)
Updated on ClinicalTrials.gov 2026-03-10